• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2022 Jun 16;1-7.
doi: 10.1080/21645515.2022.2086773. Online ahead of print.
Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study


Masaki Machida[SUP] 1 2 [/SUP], Hiroyuki Kikuchi[SUP] 1 [/SUP], Takako Kojima[SUP] 3 [/SUP], Itaru Nakamura[SUP] 2 [/SUP], Reiko Saito[SUP] 4 [/SUP], Tomoki Nakaya[SUP] 5 [/SUP], Tomoya Hanibuchi[SUP] 5 [/SUP], Tomoko Takamiya[SUP] 1 [/SUP], Yuko Odagiri[SUP] 1 [/SUP], Noritoshi Fukushima[SUP] 1 [/SUP], Shiho Amagasa[SUP] 1 [/SUP], Hidehiro Watanabe[SUP] 2 [/SUP], Shigeru Inoue[SUP] 1 [/SUP]



Affiliations

Abstract

To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18-2.54; OR: 1.58, 95%CI: 1.22-2.05; OR: 3.05, 95%CI: 2.15-4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic.

Keywords: Coronavirus disease; messenger RNA vaccine; social capital; vaccine acceptance; vaccine hesitancy.
 
Back
Top Bottom